Center for Geriatrics and Gerontology, Kaohsiung Veterans General Hospital, Kaohsiung City, Taiwan.
Aging and Health Research Center, National Yang Ming Chiao Tung University, Taipei City, Taiwan.
Br J Clin Pharmacol. 2023 Jan;89(1):187-200. doi: 10.1111/bcp.15457. Epub 2022 Aug 14.
While certain drug-use indicators are known to be associated with clinical outcomes, the relationship is unclear for some highly prevalent conditions in in patients aged ≥65 years. We examine correlations between 3 drug-use indicators and postdischarge healthcare services use by older patients according to the presence of dementia, advanced age and frailty.
This retrospective cohort study analysed data collected from hospital electronic health records between April and December 2017. Potentially inappropriate medications (PIMs) and anticholinergic burden were assessed using the 2015 Beers Criteria and anticholinergic cognitive burden scale (ACBS) score. Minor and major polypharmacy were defined as the use of 5-9 and ≥10 drugs, respectively. Outcomes were set as emergency room revisits and readmissions at 1, 3 and 6 months postdischarge. The correlation between drug-use indicators and outcomes was analysed by multivariable logistic regression.
The final cohort included 3061 patients for the analysis, and 2930, 2671 and 2560 patients were followed up to 1, 3 and 6 months after discharge. After controlling for confounders, all 3 drug-use indicators were significantly associated with readmission and emergency room revisits except for the relationship between PIMs and readmission within 6 months. These associations were significantly observed among patients without dementia, aged >80 years and with frailty.
PIMs, polypharmacy and anticholinergic burden are common at discharge and correlate with future use of healthcare services. In older patients, the absence of dementia, advanced age and frailty should be given extra consideration with regard to medication safety.
虽然某些药物使用指标与临床结果相关,但对于≥65 岁患者中一些高发疾病,其相关性尚不清楚。我们根据痴呆、高龄和衰弱情况,检查了 3 种药物使用指标与老年患者出院后医疗服务使用之间的相关性。
这项回顾性队列研究分析了 2017 年 4 月至 12 月期间从医院电子健康记录中收集的数据。使用 2015 年 Beers 标准和抗胆碱能认知负担量表 (ACBS) 评分评估潜在不适当药物 (PIM) 和抗胆碱能负担。轻度和重度多药治疗分别定义为使用 5-9 种和≥10 种药物。结果设定为出院后 1、3 和 6 个月的急诊室复诊和再入院。通过多变量逻辑回归分析药物使用指标与结果之间的相关性。
最终队列纳入了 3061 例患者进行分析,有 2930、2671 和 2560 例患者在出院后 1、3 和 6 个月进行了随访。在控制混杂因素后,除 PIM 与 6 个月内再入院的关系外,所有 3 种药物使用指标与再入院和急诊室复诊均显著相关。这些关联在没有痴呆、年龄>80 岁和衰弱的患者中更为显著。
出院时 PIM、多药治疗和抗胆碱能负担很常见,与未来医疗服务的使用相关。在老年患者中,应特别考虑无痴呆、高龄和衰弱情况下的药物安全性。